• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BIOMET UK LTD. CER OPTION TYPE 1 TPR SLEVE -3; FEMORAL HEAD/STEM PROSTHESIS ADAPTOR

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BIOMET UK LTD. CER OPTION TYPE 1 TPR SLEVE -3; FEMORAL HEAD/STEM PROSTHESIS ADAPTOR Back to Search Results
Model Number N/A
Device Problems Device Dislodged or Dislocated (2923); Unintended Movement (3026)
Patient Problems Loss of Range of Motion (2032); Discomfort (2330)
Event Date 06/11/2020
Event Type  Injury  
Manufacturer Narrative
(b)(4).Initial mdr report.Customer has indicated that the product is available to be returned to zimmer biomet for investigation.Concomitant medical products: medical product: cer bioloxd option hd 40mm, catalog #: (b)(4), lot #: 2957976.Medical product: g7 hi-wall e1 liner 40mm f, catalog #: (b)(4), lot #: 6592120.Multiple mdr reports were filed for this event, please see associated reports: 3002806535-2020-00336.The investigation is in process.Once the investigation has been completed, a follow-up mdr will be submitted.
 
Event Description
It was reported that the patient underwent an initial hip arthroplasty.Subsequently, the patient was revised due to poly liner detachment from cup.During the procedure, the head was noted to have articulated on the metal cup, so both the head and liner components were removed and replaced.Patient experienced discomfort and restricted daily activities.Attempts have been made and additional information on the reported event is unavailable at this time.
 
Manufacturer Narrative
(b)(4).This final report is being submitted to relay additional information.Multiple mdr reports were filed for this event, please see associated reports: 3002806535-2020-00336-1.Product has been returned to biomet uk ltd for evaluation and forwarded to a research engineer for investigation.A biolox delta option femoral head and a g7 hi-wall e1 liner were revised after the liner disassociated from the acetabular shell after approximately 3 months and a half in use.The available relevant manufacturing history record indicate that the items were manufactured in accordance with the applicable specifications.Visual inspection of the ceramic head showed a large metal transfer patch on its bearing surface, consistent with the reported liner disassociation and metallosis described in the provided surgical notes.Visual inspection of the g7 hi-wall e1 liner showed extensive damage, as well as some scratches to the bearing surface, around the region of the high wall, also consistent with the reported disassembly of the component form the acetabular shell.The provided surgical notes state that the acetabular polyethylene liner exhibited wear pattern associated with malposition and inappropriate weight distribution.Other factors that may have contributed to the early failure of the implant cannot be discussed without provision of the requested radiographs.The available mhr reviews indicate that the products were most likely conforming to design specification when they left zimmer biomet control.Risk assessment: risk management report documents the estimated residual risk associated with the reported event.The root cause of the issue could not be determined with the information currently available, therefore the specific failure cause within the risk tables could not be selected for comparison.The reported event states revision due to dislocation.In the risk file, dislocation is considered harm with a severity level of 3 for a number of hazards defined as moderate, which is described in the severity table as: s-3 prescribed medical or surgical intervention to preclude permanent impairment of a body function or body structure.Contributed to minor, temporary, or medically reversible injury.The outcome of the reported event (surgical intervention) is considered to be within the severity of the rmf.No corrective or preventive actions are deemed necessary at this time.If any further information is found which would change or alter any conclusions or information, a supplemental will be filed accordingly.Zimmer biomet will continue to monitor for trends.
 
Event Description
It was reported that the patient underwent an initial hip arthroplasty.Subsequently, the patient was revised due to poly liner detachment from cup.During the procedure, the head was noted to have articulated on the metal cup, so both the head and liner components were removed and replaced.Patient experienced discomfort and restricted daily activities.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
CER OPTION TYPE 1 TPR SLEVE -3
Type of Device
FEMORAL HEAD/STEM PROSTHESIS ADAPTOR
Manufacturer (Section D)
BIOMET UK LTD.
waterton industrial estates
bridgend CF31 3XA
UK  CF31 3XA
MDR Report Key10332401
MDR Text Key201388076
Report Number3002806535-2020-00337
Device Sequence Number1
Product Code LPH
Combination Product (y/n)N
PMA/PMN Number
K082996
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,health
Type of Report Initial,Followup
Report Date 12/17/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model NumberN/A
Device Catalogue Number650-1065
Device Lot Number2936757
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer12/01/2020
Was the Report Sent to FDA? No
Initial Date Manufacturer Received 06/30/2020
Initial Date FDA Received07/28/2020
Supplement Dates Manufacturer Received12/17/2020
Supplement Dates FDA Received12/17/2020
Is This a Reprocessed and Reused Single-Use Device? No
Removal/Correction NumberN/A
Patient Sequence Number1
Treatment
SRRH10
Patient Outcome(s) Hospitalization; Required Intervention;
Patient Age65 YR
-
-